Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Mepha is a Swiss-based innovative pharmaceutical company developing, manufacturing and marketing branded and non-branded generic products in more than 50 countries. Mepha manufactures many of its products in Aesch/Basel -- Switzerland, to a high Swiss-quality standard. Mepha’s R & D organization has developed improved branded generics either through new formulations or using drug delivery technologies, providing additional benefits for healthcare professionals and patients. Furthermore, Mepha is actively involved in researching malaria treatments for adults and children.

INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION provides practical help for improving the technology of an industrial field.

Cellix Bio Pvt Ltd. is a biopharmaceutical company, which engages in the development and discovery of novel drugs. It specializes in the treatment of neurology, dermatology, gastrointestinal, inflammation, metabolic and life style, oncology, ophthalmology, and infectious diseases. The company was founded by Mahesh Kandula on May 21, 2014 and is headquartered in Hyderabad, India.

Marnac, Inc. is a private company headquartered in Allen, TX. The firm develops and markets pharmaceutical products.

BrosMed Medical Co., Ltd. operates as a medical device design and manufacturing company. It develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices. The firm’s product line consists of interventional cardiovascular catheter series and endovascular catheter series. The company was founded by Benny Lee in 2012 and is headquartered in Dongguan, China.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Huadu Ruixi Modern Industrial Technology Development (Hainan) Co., Ltd., established on 2021-08-30, Business scope includes licensed projects:Betel nut processing;food business(sell bulk food);road freight transport(Does not contain dangerous goods)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Food Internet Sales(Only sell prepackaged food);production of agricultural products,Sales,processing,transportation,Storage and other related services;Primary processing of edible agricultural products;Retailing of Edible Agricultural Products;Aquatic planting(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Biomaster, Inc. engages in the operation and management of a hospitals. It specializes in cell-assisted lipotransfer tissue augmentation procedures. It offers various medical services using cell-assisted lipotransfer tissue augmentation procedures, such as breast augmentation, breast reconstruction and restoration, wrinkle removal, and buttock lift. It also involves in the integration of regenerative medicine and plastic surgery, as well as offers various services, including cell source development, tissue/cell banking, development and sale of devices, development of cell preservation, cultivation, and transplantation technologies. The company was founded on December 25, 2002 and is headquartered in Yokohama, Japan.

Dalian Bo Ruisen Biomedical Technology Co., Ltd., established on 2015-08-17, Business scope includes biomedical technology development,technical consulting,Technical Services;Bioscience and Technology Research Services;Biotechnology Extension Services;Technology Import and Export,Import and export;Domestic general trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Chengdu Peide Biopharmaceutical Co., Ltd., established on 2021-05-21, Business scope includes licensed projects:pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;R&D and application of cell technology;Pharmaceutical special equipment manufacturing;Artificial intelligence basic software development;Artificial intelligence application software development;Big data service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

KDL GmbH is a private company headquartered in Vechta, Germany, that provides telecommunication services. The firm was founded in 2001.

Suzhou Deruite Imaging Technology Co., Ltd., established on 2014-07-10, Business scope includes general items:Wholesale of computer software, hardware and auxiliary equipment;Computer and communication equipment rental;Information security equipment sales;Internet equipment sales;Network Equipment Sales;electronics sales;Computer and Office Equipment Repair;Cloud Computing Equipment Sales;Computer System Services;Technology promotion and application services;software development;software sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Information Technology Consulting Services;Information system operation and maintenance services;Instrument sales;Optical Instrument Sales;Optical Glass Sales;Camera and Equipment Sales;Vibration and noise reduction equipment sales;Communication equipment sales;Sales of electronic special equipment;Smart Instrument Sales;marketing planning;Project planning and public relations services;Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. In pulmonology, they are focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. Pirfenidone, the only medicine approved for IPF anywhere in the world, is approved for marketing by InterMune in the EU as Esbriet® and is currently in a Phase 3 clinical trial to support regulatory registration in the United States. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases.